Rani Therapeutics Holdings (RANI) Equity Ratio (2020 - 2025)
Historic Equity Ratio for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to 1.18.
- Rani Therapeutics Holdings' Equity Ratio fell 99031.62% to 1.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.18, marking a year-over-year decrease of 99031.62%. This contributed to the annual value of 0.1 for FY2024, which is 7829.58% down from last year.
- As of Q3 2025, Rani Therapeutics Holdings' Equity Ratio stood at 1.18, which was down 99031.62% from 0.54 recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Equity Ratio ranged from a high of 0.98 in Q4 2021 and a low of 1.6 during Q2 2021
- For the 5-year period, Rani Therapeutics Holdings' Equity Ratio averaged around 0.25, with its median value being 0.47 (2023).
- Its Equity Ratio has fluctuated over the past 5 years, first soared by 16857.93% in 2021, then tumbled by 99031.62% in 2025.
- Rani Therapeutics Holdings' Equity Ratio (Quarter) stood at 0.98 in 2021, then tumbled by 30.01% to 0.69 in 2022, then tumbled by 35.87% to 0.44 in 2023, then tumbled by 78.3% to 0.1 in 2024, then plummeted by 1338.49% to 1.18 in 2025.
- Its last three reported values are 1.18 in Q3 2025, 0.54 for Q2 2025, and 0.22 during Q1 2025.